WV HB4721 | 2026 | Regular Session
Status
Sponsorship: Partisan Bill (Republican 2)
Status: Introduced on January 22 2026 - 25% progression
Action: 2026-01-22 - To House Health and Human Resources
Pending: House Health & Human Resources Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 22 2026 - 25% progression
Action: 2026-01-22 - To House Health and Human Resources
Pending: House Health & Human Resources Committee
Text: Latest bill text (Introduced) [HTML]
Summary
The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.
Title
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2026-01-22 | House | To House Health and Human Resources |
| 2026-01-22 | House | Introduced in House |
| 2026-01-22 | House | To Health and Human Resources then Judiciary |
| 2026-01-22 | House | Filed for introduction |
Same As/Similar To
HB4640 (Similar To) 2026-02-02 - On 1st reading, House Calendar
Subjects
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 60A | 2 | 204 | Amended Code | Citation Text |
